REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

PharmaCore Biotech Co., Ltd. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: PharmaCore Biotech Co., Ltd. Profile Updated: October 20, 2022
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English & Chinese Download a sample report

PharmaCore Biotech Co., Ltd. is mainly engaged in the development and manufacture of APIs and preparations. The company was founded in 2015 and is headquartered in Tainan City, Taiwan.

Headquarters
5F., No.2, Ln. 31, Sec. 1, Huandong Rd., Xinshi Dist., Tainan, Taiwan
Tainan City; Tainan City;

Contact Details: Purchase the PharmaCore Biotech Co., Ltd. report to view the information.

Website: http://www.pharmacore-biotech.com

Basic Information
Total Employees:
Purchase the PharmaCore Biotech Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the PharmaCore Biotech Co., Ltd. report to view the information.
Financial Auditors:
Purchase the PharmaCore Biotech Co., Ltd. report to view the information.
Incorporation Date:
January 08, 2015
Key Executives
Purchase this report to view the information.
Chairman of the Board of Directors
Purchase this report to view the information.
President
Purchase this report to view the information.
Spokesperson
Ownership Details
Purchase this report to view the information.
24.6%
Company Performance
Financial values in the chart are available after PharmaCore Biotech Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-71.72%▼
Total operating revenue
-71.72%▼
Operating profit (EBIT)
-33.39%▼
EBITDA
-42.52%▼
Net Profit (Loss) for the Period
-24.54%▼
Total assets
-9.45%▼
Total equity
-44.32%▼
Operating Profit Margin (ROS)
-378.05%▼
Net Profit Margin
-367%▼
Return on Equity (ROE)
-74.99%▼
Debt to Equity Ratio
87.15%▲
Quick Ratio
-0.47%▼
Cash Ratio
-0.16%▼

To view more information, Request a demonstration of the EMIS service

USD 19.99
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo